pharmaphorum

SEPTEMBER 23, 2021

Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing for their COVID-19 vaccine, based on a conventional recombinant protein technology. Getting a WHO emergency use listing (EUL) is a requirement for approvals by many national regulatory authorities, as well as for participation in the COVAX mechanism, which has been set up to procure COVID-19 vaccines for lower-income countries.

Vaccines 117

Vaccines 117

Pharma Times

SEPTEMBER 21, 2021

Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19

133

133

Drug Patent Watch

SEPTEMBER 20, 2021

I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…. The post Workshop and lecture on generic portfolio management appeared first on DrugPatentWatch - Make Better Decisions.

105

105

Pharma Mirror

SEPTEMBER 18, 2021

25th September is celebrated as world pharmacists day, and it brings a new theme every year. The main motive behind this celebration is to give an excellent message to improve people’s health worldwide. And also, create an acceptance and encourage the role of a pharmacist in health. The pharmacist community from all over the world arranges different campaigns, exhibitions, lectures, etc., for serving this purpose.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

SEPTEMBER 23, 2021

A study has found that listening to a specially composed music track can achieve “clinically significant” reductions in pain intensity and unpleasantness, according to the researchers behind the work. The All of Us track – composed by musician Anatole with the help of psychologist Dr Claire Howlin of University College Dublin and available via Spotify – reportedly showed a benefit in 286 people suffering from various types of acute pain, including headache, backache or period pain in

114

114

Pharma Times

SEPTEMBER 24, 2021

Trial will test if radium-223 plus avelumab can improve outcomes for metastatic breast cancer patients

130

130

Outsourcing Pharma

SEPTEMBER 21, 2021

According to a leader from the health engagement solutions firm, intelligent use of technology tools can add patient-centricity and realism to a study.

101

101

pharmaphorum

SEPTEMBER 21, 2021

RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies. RwHealth’s unique Data Science Platform combines Artificial Intelligence (AI), Machine Learning and Data Science to give healthcare providers access to the best and most in-depth data available, helping them to make better decisi

Hospitals 104

Hospitals Pharmaceutical Companies Pharmaceutical Companies 104

NY Times

SEPTEMBER 18, 2021

Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.

96

96

Drug Patent Watch

SEPTEMBER 23, 2021

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-two patents protecting…. The post New patent for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.

90

90

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

SEPTEMBER 20, 2021

'Groundbreaking results' for the treatment of HER2-positive metastatic breast cancer

121

121

pharmaphorum

SEPTEMBER 22, 2021

An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review. The study , led by the Chief Pharmaceutical Officer for England Dr Keith Ridge, estimates that 10% of items dispensed in primary care are inappropriate or could be better served with alternative treatments.

Hospitals 104

Hospitals 104

NY Times

SEPTEMBER 23, 2021

Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday.

Immunity 89

Immunity Immunization Vaccines 89

Outsourcing Pharma

SEPTEMBER 22, 2021

A logistics leader from the CRO offers advice on navigating borders, cultures, regulatory issues and other important considerations on worldwide studies.

95

95

Pharma Times

SEPTEMBER 21, 2021

Cabometyx found to reduce the risk of disease progression or death versus placebo in this patient population

105

105

pharmaphorum

SEPTEMBER 22, 2021

The third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on the lessons he learned from his father and grandfather – and from his work as a former management consultant – about what it means to run a successful family business and its benefits. Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global emplo

Immunity 104

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 104

NY Times

SEPTEMBER 21, 2021

The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.

Specialty Pharmacies 90

Specialty Pharmacies Labelling Packaging 90

Drug Channels

SEPTEMBER 23, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Click here to see the original post and comments from May 2021. Last week, Cigna released its earnings for the first quarter of 2021. Links below. I was struck by how quickly Cigna’s Express Scripts PBM business has increased revenues and prescriptions from its retail pharmacy network.

72

72

Pharma Times

SEPTEMBER 22, 2021

Cancer Research UK has partnered with the University of Edinburgh's ‘venture builder incubator’

101

101

pharmaphorum

SEPTEMBER 22, 2021

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. The charity says AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax, and Pfizer are fuelling an “unprecedented human rights crisis” as a result and their failure to act “paints a dismal picture of an industry that is woefully failing to respect human rights.”

Vaccines 103

Vaccines 103

NY Times

SEPTEMBER 24, 2021

The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.

Vaccines 67

Vaccines 67

Drug Channels

SEPTEMBER 20, 2021

Informa Connect's Pharma/Biotech GTN Summit. Hybrid Event In-Person: November 17-19, 2021 in Philadelphia Virtual: November 22-23, 2021 www.informaconnect.com/gtn. Join the life sciences community this fall at Informa Connect’s GTN Summit , now in the 11th year. Whether you register with an All-Access Pass (attending in-person on November 17-19, 2021 with access to Virtual content) or register with a Virtual Pass (attending from your home or office on November 22-23, 2021 with access to the In-P

Drug Pricing 65

Drug Pricing 65

Pharma Times

SEPTEMBER 22, 2021

Positive opinions recommend approval for mAb in three additional eosinophil-driven diseases

107

107

pharmaphorum

SEPTEMBER 19, 2021

AstraZeneca and Daiichi Sankyo were clearly excited by data from a trial pitting their HER2 antibody-drug conjugate (ADC) Enhertu against Roche’s rival Kadcyla when they reported top-line results last month – and a look at the full data set reveals why. In the DESTINY-Breast03 trial, Enhertu (trastuzumab deruxtecan) reduced the risk of disease progression or death compared to Kadcyla (trastuzumab emtansine) by 72% in patients with HER2-positive, advanced breast cancer who had previously tr

Chemotherapy 100

Chemotherapy Labelling 100

Outsourcing Pharma

SEPTEMBER 22, 2021

SmartSignals Supplies is designed to help trial teams get a handle on clinical trial supply chain management to avoid delays, waste, and cost overruns.

69

69

NY Times

SEPTEMBER 19, 2021

Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses within a year.

Vaccines 57

Vaccines Immunity Immunization 57

Pharma Times

SEPTEMBER 24, 2021

Results showed treatment with Crysvita reduces disease burden for patients

113

113

pharmaphorum

SEPTEMBER 19, 2021

Any lingering hope that Pfizer’s may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after the EMA’s human medicines committee rejected the drug. A positive recommendation was already looking like a long shot for after FDA advisors voted 15 to one against approval of the drug in March.

98

98

Outsourcing Pharma

SEPTEMBER 24, 2021

As COVID-19 and its variants continue their attack, the agency maintains its position of overseer and giver of advice on various treatments and vaccines.

Vaccines 67

Vaccines 67

Drug Patent Watch

SEPTEMBER 24, 2021

Annual Drug Patent Expirations for GENOSYL Genosyl is a drug marketed by Vero Biotech and is included in one NDA. There are nineteen patents protecting this drug. This drug has…. The post New patent for Vero Biotech drug GENOSYL appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 20, 2021

Drug combination could offer a new option for treatment-resistant advanced ovarian cancer

105

105

pharmaphorum

SEPTEMBER 24, 2021

Targeting people for COVID-19 vaccination using contract-tracing apps could be a shortcut to achieving herd immunity in the population using fewer doses, according to Canadian researchers. According to Mark Penney, Yigit Yargic and colleagues from the Perimeter Institute for Theoretical Physics in Ontario, targeting vaccines to people who have more exposure than others is the most effective way to reduce transmission of SARS-CoV-2.

Vaccines 97

Vaccines Immunity Immunization 97

Outsourcing Pharma

SEPTEMBER 20, 2021

Two experts from the contract research organization offer advice on planning and executing clinical studies with the unique needs of such patients in mind.

64

64

Drug Patent Watch

SEPTEMBER 24, 2021

Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are twelve patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 21, 2021

Adagrasib is an investigational oral small-molecule inhibitor of KRAS G12C

112

112